share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Adial Pharmaceuticals | 4：持股变动声明
美股SEC公告 ·  03/28 06:25

Moomoo AI 已提取核心信息

In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
在最近于2024年3月25日进行的一笔交易中，与艾迪尔制药（ADIL.US）相关的罗伯逊·吉利兰参与了一次股市事件。有关交易性质的具体细节，例如交易的股票数量、交易价格和由此产生的股权，没有披露。关注Adial Pharmicals的投资者可能会对这一事件感兴趣，因为内幕交易可以为公司的财务状况和未来前景提供见解。
在最近于2024年3月25日进行的一笔交易中，与艾迪尔制药（ADIL.US）相关的罗伯逊·吉利兰参与了一次股市事件。有关交易性质的具体细节，例如交易的股票数量、交易价格和由此产生的股权，没有披露。关注Adial Pharmicals的投资者可能会对这一事件感兴趣，因为内幕交易可以为公司的财务状况和未来前景提供见解。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间